Crossmark

A case of neoadjuvant targeted therapy with pralsetinib for locally advanced lung adenocarcinoma with RET fusion mutation

Published Online: 2024-10-01

Authors

Chunmao, Wang

Haijie, Cheng

Zitong, Wang

Zhi, Yang
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-01
More Information

Article History

Received: 4 May 2024

Accepted: 15 September 2024

First Online: 1 October 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current